first glp-1 drug Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Trends in the Development of
Description
Thats why theres a lot of excitement around a new pill form of the drug

Learn how they compare to find the medication that best suits your needs.

Maximize your GLP-1 results

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron
